Ticker Details
Avidity Biosciences, Inc.
IPO Date:	June 12, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$10.21B
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.76 | 3.27%
Avg Daily Range (30 D):	$1.16 | 2.54%
Avg Daily Range (90 D):	$1.09 | 2.65%

Institutional Daily Volume
Avg Daily Volume:	.86M
Avg Daily Volume (30 D):	4.5M
Avg Daily Volume (90 D):	3.25M

Trade Size
Avg Trade Size (Sh.):	80
Avg Trade Size (Sh.) (30 D):	139
Avg Trade Size (Sh.) (90 D):	101

Institutional Trades
Total Institutional Trades:	3,446
Avg Institutional Trade:	$3.39M
Avg Institutional Trade (30 D):	$4.92M
Avg Institutional Trade (90 D):	$4.65M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$4.56M
Avg Closing Trade (30 D):	$20.67M
Avg Closing Trade (90 D):	$14.74M
Avg Closing Volume:	163.69K

News

Jan 31, 2026 @ 5:58 PM Halper Sadeh LLC Encourages TWO, RNA, CVBF, TBN Sh... Source: Halper Sadeh Llc

Jan 31, 2026 @ 3:46 AM $HAREHOLDER ALERT: The M&A Class Action Firm Conti... Source: Prnewswire

Nov 22, 2025 @ 10:34 AM Halper Sadeh LLC Encourages WTRG, RNA, TCBX Shareh... Source: Halper Sadeh Llc

Nov 20, 2025 @ 5:43 PM Novartis Projects Faster Growth Through 2030 After... Source: Vandana Singh

Oct 28, 2025 @ 10:58 AM Novartis Maintains Outlook Even As Generics Bite I... Source: Vandana Singh

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$-1.18	$-.97
Diluted EPS		$-1.18	$-.97
Revenue		$3M	$19.64M
Gross Profit
Net Income / Loss		$-20.19M	$-16.63M
Operating Income / Loss		$-22.62M	$-17.28M
Cost of Revenue
Net Cash Flow		$-195.51M	$268.26M
PE Ratio